Altimmune (ALT) EBT Margin (2010 - 2025)
Altimmune (ALT) recorded EBT Margin of -105223.08% in Q4 2025, up 358376.92 percentage points from -463600.00% a year earlier and up 275056.92 percentage points from the prior quarter.
Powered by 
Analysis
Altimmune (ALT) EBT Margin (2010 - 2025) Analysis & Trends
For FY2025, Altimmune reported EBT Margin of -216521.95%, up 258773.05 percentage points from FY2024.
- Annual EBT Margin has a five-year change of -215856.57 percentage points (FY2020 to FY2025).
- Across earlier years, EBT Margin came in at -475295.00% in FY2024 (-454532.79 pp), -20762.21% in FY2023 (+104105.44 pp), -124867.65% in FY2022 (-122666.06 pp) and -2201.59% in FY2021 (-1536.21 pp).
- The Q4 2025 figure is the highest quarterly EBT Margin since Q4 2023.
- On a year-over-year basis, EBT Margin has increased for four consecutive quarters, with an average year-over-year change of -109633.63 percentage points over the last eight quarters.
- Peak year-over-year performance for EBT Margin in the last five years was a gain of 1179939.78 percentage points in Q3 2023, against a drop of 1164441.14 percentage points in Q3 2022 at the low end.
- Per Business Quant, the preceding three quarters came in at -380280.00% (Q3 2025), -442920.00% (Q2 2025) and -405120.00% (Q1 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 26.66% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 25.18% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | -4.11% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 29.63% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 18.19% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 27.53% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -131.41% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | -4.34% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 41.75% |
| 10 | Altimmune | 575.64 Mn | 575.64 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -105,223.08% |
| Sep 30, 2025 | -380,280.00% |
| Jun 30, 2025 | -442,920.00% |
| Mar 31, 2025 | -405,120.00% |
| Dec 31, 2024 | -463,600.00% |
| Sep 30, 2024 | -456,900.00% |
| Jun 30, 2024 | -492,800.00% |
| Mar 31, 2024 | -487,880.00% |
| Dec 31, 2023 | -85,516.22% |
| Sep 30, 2023 | -5,710.22% |
| Jun 30, 2023 | -269,566.67% |
| Mar 31, 2023 | -95,680.95% |
| Dec 31, 2022 | -83,307.69% |
| Sep 30, 2022 | -1,185,650.00% |
| Jun 30, 2022 | -251,650.00% |
| Mar 31, 2022 | -61,062.50% |
| Dec 31, 2021 | -728.99% |
| Sep 30, 2021 | -21,208.86% |
| Jun 30, 2021 | -18,121.68% |
| Mar 31, 2021 | -1,773.76% |
API Access
Altimmune EBT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebt-margin&ticker=ALT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebt-margin", "ticker": "ALT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebt-margin&ticker=ALT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();